Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

GDF-15 Neutralization Alleviates Platinum-Based Chemotherapy-Induced Emesis, Anorexia, and Weight Loss in Mice and Nonhuman Primates
Danna M. Breen, Hanna Kim, Donald Bennett, et al.
Cell Metabolism (2020) Vol. 32, Iss. 6, pp. 938-950.e6
Open Access | Times Cited: 122

Showing 26-50 of 122 citing articles:

Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours
Ignacio Melero, María de Miguel Luken, Guillermo de Velasco, et al.
Nature (2024)
Open Access | Times Cited: 8
Management of nausea and vomiting induced by antibody–drug conjugates
Jawhara Farhat, Hitomi Sakai, Junji Tsurutani
Breast Cancer (2025)
Open Access | Times Cited: 1
The Metabolic Basis of Cancer-Related Fatigue
Robert Dantzer, Brandon Chelette, Elisabeth G. Vichaya, et al.
Neuroscience & Biobehavioral Reviews (2025), pp. 106035-106035
Closed Access | Times Cited: 1
Engineered CAF-cancer cell hybrid membrane biomimetic dual-targeted integrated platform for multi-dimensional treatment of ovarian cancer
Yuwei Yao, Jiarui Zhang, Kexin Huang, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Whole‐exome sequencing uncovers new variants in GDF15 associated with hyperemesis gravidarum
Marlena S. Fejzo, Kimber MacGibbon, Olivia First, et al.
BJOG An International Journal of Obstetrics & Gynaecology (2022) Vol. 129, Iss. 11, pp. 1845-1852
Open Access | Times Cited: 32
Knocking on GDF15’s door for the treatment of type 2 diabetes mellitus
David Aguilar-Recarte, Emma Barroso, Xavier Palomer, et al.
Trends in Endocrinology and Metabolism (2022) Vol. 33, Iss. 11, pp. 741-754
Closed Access | Times Cited: 28
A Phase Ib First-In-Patient Study Assessing the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ponsegromab in Participants with Cancer and Cachexia
Jeffrey Crawford, Roberto A. Calle, Susie M. Collins, et al.
Clinical Cancer Research (2023) Vol. 30, Iss. 3, pp. 489-497
Open Access | Times Cited: 21
Chemotherapy-induced gastrointestinal toxicity: Pathogenesis and current management
Yunjing He, Jingrui Zheng, Binbin Ye, et al.
Biochemical Pharmacology (2023) Vol. 216, pp. 115787-115787
Closed Access | Times Cited: 18
GDF15 in Appetite and Exercise: Essential Player or Coincidental Bystander?
Anders B. Klein, Maximilian Kleinert, Erik A. Richter, et al.
Endocrinology (2021) Vol. 163, Iss. 1
Open Access | Times Cited: 37
Body weight regulation via MT1-MMP-mediated cleavage of GFRAL
Chi Fung Willis Chow, Xuanming Guo, Pallavi Asthana, et al.
Nature Metabolism (2022) Vol. 4, Iss. 2, pp. 203-212
Closed Access | Times Cited: 26
Camptothecin effectively treats obesity in mice through GDF15 induction
Jun Lu, Mengqing Zhu, Baocai Xie, et al.
PLoS Biology (2022) Vol. 20, Iss. 2, pp. e3001517-e3001517
Open Access | Times Cited: 26
The GDF15-GFRAL pathway is dispensable for the effects of metformin on energy balance
Anders B. Klein, Trine S. Nicolaisen, Kornelia Johann, et al.
Cell Reports (2022) Vol. 40, Iss. 8, pp. 111258-111258
Open Access | Times Cited: 26
Pathological consequences of DNA damage in the kidney
Juan I. Garaycoechea, Catherine Quinlan, Martijn S. Luijsterburg
Nature Reviews Nephrology (2023) Vol. 19, Iss. 4, pp. 229-243
Closed Access | Times Cited: 15
CHAC1 inactivation is effective to preserve muscle glutathione but is insufficient to protect against muscle wasting in cachexia
Junjie Li, Mingjian Lu, Youngwook Ahn, et al.
PLoS ONE (2023) Vol. 18, Iss. 4, pp. e0283806-e0283806
Open Access | Times Cited: 14
GDNF family receptor alpha‐like antagonist antibody alleviates chemotherapy‐induced cachexia in melanoma‐bearing mice
Beom Yong Lee, Jongwon Jeong, Inseong Jung, et al.
Journal of Cachexia Sarcopenia and Muscle (2023) Vol. 14, Iss. 3, pp. 1441-1453
Open Access | Times Cited: 14
GIP receptor agonism blocks chemotherapy-induced nausea and vomiting
Tito Borner, Benjamin C. Reiner, Richard C. Crist, et al.
Molecular Metabolism (2023) Vol. 73, pp. 101743-101743
Open Access | Times Cited: 14
Hepatic IRE1α-XBP1 signaling promotes GDF15-mediated anorexia and body weight loss in chemotherapy
Yuexiao Tang, Tao Yao, Xin Tian, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 7
Closed Access | Times Cited: 5
Cancer cachexia: multilevel metabolic dysfunction
Mauricio Berriel Díaz, Maria Rohm, Stephan Herzig
Nature Metabolism (2024)
Closed Access | Times Cited: 5
Mechanisms and pharmacotherapy of cancer cachexia‐associated anorexia
Ryosuke Sato, Guilherme Wesley Peixoto da Fonseca, Willian das Neves, et al.
Pharmacology Research & Perspectives (2025) Vol. 13, Iss. 1
Open Access
Antiemetic activity of Sesamol possibly through serotonergic and dopaminergic receptor interaction pathways: In vivo and in silico studies
Touhidul Islam Tanim, Ayman M. Al‐Qaaneh, Raihan Chowdhury, et al.
Journal of Functional Foods (2025) Vol. 126, pp. 106702-106702
Open Access
GDF‐15 blockade: A multi‐directional approach to potentiate cancer immunotherapy and alleviate cancer cachexia
Ignacio Melero, Kathrin Klar, Eugen Leo
Clinical and Translational Medicine (2025) Vol. 15, Iss. 4
Open Access
Clinical and Tumor Characteristics of Patients with High Serum Levels of Growth Differentiation Factor 15 in Advanced Pancreatic Cancer
Hidetaka Suzuki, Shuichi Mitsunaga, Masafumi Ikeda, et al.
Cancers (2021) Vol. 13, Iss. 19, pp. 4842-4842
Open Access | Times Cited: 27
Circulating total and intact GDF-15 levels are not altered in response to weight loss induced by liraglutide or lorcaserin treatment in humans with obesity
Laura Valenzuela‐Vallejo, Pavlina Chrysafi, Jenny C. Bello-Ramos, et al.
Metabolism (2022) Vol. 133, pp. 155237-155237
Closed Access | Times Cited: 20
Cancer cachexia as a multiorgan failure: Reconstruction of the crime scene
Michele Ferrara, Maria Samaden, Elena Ruggieri, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 20
Effects of a semi-interpenetrating network hydrogel loaded with oridonin and DNase-I on the healing of chemoradiotherapy-induced oral mucositis
Yuxue Pan, Mengyuan Wang, Peng Wang, et al.
Biomaterials Science (2024) Vol. 12, Iss. 17, pp. 4452-4470
Closed Access | Times Cited: 4

Scroll to top